…patients with delirium stratified by AKI severity or receipt of renal replacement therapy as well as clinical factors associated with delirium, mortality…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 155 of 2459…erapy will be included and randomised 1:1 to receive either (1) docetaxel (or paclitaxel), carboplatin, trastuzumab (H) and pertuzumab (P…
…se-related characteristics.Methods A cross-sectional study at a tertiary centre surveyed adult orthopaedic surgery patients 6 weeks post-surger…
…ged. Reductions in TB and DB were observed after treatment with maralixibat. No clinically meaningful changes in ALT or AST were observed w…
…uding adalimumab, infliximab and vedolizumab, prior to starting Ustekinumab. 12/21 patients stopped treatment because of poor response. 4/1…
…Oesophageal strictures in the paediatric population pose a significant clinical challe…
…Background Acute coronary syndrome (ACS) is a major cause of mortality, with over 80,000 annual UK…
… (3%) Atrial Fibrillation 264 (38%) 138 (27%) 101 (19%) 17 (4%) Kidney Disease 190 (27%) 471 (92%) 27 (5%) 52 (11%) Diabetes 62 (9%) 333 (66%)…
…n buffer power (59.2±6.4 in control and 93.5±7.9 in HF p=0.02). Tadalafil treatment resulted in an increase in Kd to 1.25±0.13 µM (p=0.01…
…860; P=0.0082), and in-hospital mortality (OR=0.590; P=0.0003). Alcohol use was linked to increased extended length of stay (OR=1.363; …